Phoenix Bio

NEWS

NEWS

LATEST INFORMATION

December 13, 2017

Result from Studies using PXB-Mouse and PXB-cells being presented at HepDART 2017

November 15, 2017

PhoenixBio Announces Strategic Acquisition of KMT Hepatech, Inc.

PhoenixBio Co., Ltd. today announced that it has entered into a definitive agreement to acquire KMT Hepatech, Inc., a privately held contract research organization focused on providing services with a chimeric mouse model. KMT will wholly become a part of the PhoenixBio group effective November 30th, 2017.

October 19, 2017

Result from Studies featuring PXB-mice & PXB-cells being presented at AASLD 2017

September 20, 2017

Result from Studies featuring PXB-mice being presented at 21st North American ISSX Meeting

September 13, 2017

Result from Studies using PXB-Mouse and PXB-cells being presented at 2017 International HBV Meeting (Including additional presentation)

September 07, 2017

PhoenixBio to present its services at 53rd Congress of the European Societies of Toxicology 2017

We will be presenting our commercial services at 53rd Congress of the European Societies of Toxicology 2017.

The meeting is held in Bratislava, Slovakia from September 10th to 13th.

September 01, 2017

Result from Studies using PXB-Mouse being presented at 2017 International HBV Meeting

June 20, 2017

Result from Studies using PXB-cells being presented at 14th European ISSX Meeting